作者: Thomas C. Hanff , Edo Y. Birati
DOI: 10.1007/S11897-019-00438-X
关键词:
摘要: The purpose of this review is to synthesize and summarize recent developments in the care patients with end-stage heart failure being managed a left ventricular assist device (LVAD) as destination therapy. Although survival treated LVAD continues improve, rates LVAD-associated complication, such right failure, bleeding complications, major infection, remain high, management these remains challenging. durability hemocompatibility support have greatly increased years result new technologies novel strategies. Challenges comprehensive therapy LVADs, including comorbidities optimizing patient function quality life.